OpenVSafe by OpenVAERS
Search V-safe

U3Y-25029-06631

1 vaccination 3 coded responses 12 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
0-4
ZIP prefix
231 / VA
Registered
2022-06-25
Relationship
Child or adolescent in my care
Guardian
4AB-53733-30323
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-06-23
    Dose 1 — Pfizer-BioNTech
  2. 2022-06-25
    Registered in v-safe
  3. 2022-06-25
    Survey response — days 1–6 daily, dose 1, under 3
    MedDRA: Unevaluable event — Feeling: Good · Site: Pain · Irritability/crying
    Free text: Clinginess
    MedDRA releases: 2024-11 · check-in free text available
  4. 2022-06-26
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Site: Pain · None
    Under 3 check-in
  5. 2022-06-27
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Site: Pain · None
    Under 3 check-in
  6. 2022-06-29
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-06-30
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2022-07-09
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  9. 2022-07-16
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  10. 2022-07-21
    Health check-in — day 28, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  11. 2022-07-28
    Health check-in — day 35, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  12. 2022-09-22
    Survey response — 3 months, dose 1, under 3
    MedDRA: Body temperature increased, Cough, Nasopharyngitis, Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to work or attend school
    Free text: What seems to be a minor coldsneezing, runny nose, mild fever (100.1), occasional cough. Have not tested for COVID.
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-12-22
    Survey response — 6 months, dose 1, under 3
    MedDRA: Ear infection, Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Several colds (none confirmed COVID), ear infection
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-12-22
    Report sent to call center — 6 months, dose 1, under 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  15. 2022-12-23
  16. 2023-06-25
    Health check-in — 12 months, dose 1, under 3
    Feeling: Fair
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12022-06-23Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 12 (Under 3) — days 1–6 daily, dose 1, under 3

2022-06-25

Systemic reaction (other): Clinginess

Release 12 (Under 3) — 3 months, dose 1, under 3

2022-09-22

Symptoms: What seems to be a minor coldsneezing, runny nose, mild fever (100.1), occasional cough. Have not tested for COVID.

Release 12 (Under 3) — 6 months, dose 1, under 3

2022-12-22

Symptoms: Several colds (none confirmed COVID), ear infection

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBody temperature increased · · ✓
SDCough · · ✓
SDEar infection · · ✓
SDNasopharyngitis · · ✓
SDRhinorrhoea · · ✓
SDSneezing · · ✓
SROUnevaluable event · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release